BD’s third quarter results were broadly in line with Wall Street expectations, reflecting resilience across most of its ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2025 fourth quarter and full year, which ended September 30, 2025.
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - diversified ...